[1]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PLASMID=pE194;
DOI=10.1093/nar/8.24.6081; PubMed=6162157 [NCBI, ExPASy, EBI, Israel, Japan]
Gryczan T.J.,
Grandi G.,
Hahn J.,
Grandi R.,
Dubnau D.;
"Conformational alteration of mRNA structure and the posttranscriptional regulation of erythromycin-induced drug resistance.";
Nucleic Acids Res. 8:6081-6097(1980).
|
[2]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PLASMID=pE194;
PubMed=6938954 [NCBI, ExPASy, EBI, Israel, Japan]
Horinouchi S.,
Weisblum B.;
"Posttranscriptional modification of mRNA conformation: mechanism that regulates erythromycin-induced resistance.";
Proc. Natl. Acad. Sci. U.S.A. 77:7079-7083(1980).
|
[3]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-48.
PLASMID=pT48;
PubMed=3141573 [NCBI, ExPASy, EBI, Israel, Japan]
Catchpole I.,
Thomas C.,
Davies A.,
Dyke K.G.H.;
"The nucleotide sequence of Staphylococcus aureus plasmid pT48 conferring inducible macrolide-lincosamide-streptogramin B resistance and comparison with similar plasmids expressing constitutive resistance.";
J. Gen. Microbiol. 134:697-709(1988).
|
[4]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-40.
PLASMID=pA22;
DOI=10.1016/0378-1097(90)90410-R; PubMed=2116351 [NCBI, ExPASy, EBI, Israel, Japan]
Catchpole I.,
Dyke K.G.H.;
"A Staphylococcus aureus plasmid that specifies constitutive macrolide-lincosamide-streptogramin B resistance contains a novel deletion in the ermC attenuator.";
FEMS Microbiol. Lett. 57:43-47(1990).
|
[5]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-11.
PLASMID=pE194;
DOI=10.1016/0022-2836(85)90061-0; PubMed=2414456 [NCBI, ExPASy, EBI, Israel, Japan]
Mayford M.,
Weisblum B.;
"Messenger RNA from Staphylococcus aureus that specifies macrolide-lincosamide-streptogramin resistance. Demonstration of its conformations and of the leader peptide it encodes.";
J. Mol. Biol. 185:769-780(1985).
|
|